Kelly McCann

2.2k total citations
36 papers, 986 citations indexed

About

Kelly McCann is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kelly McCann has authored 36 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kelly McCann's work include DNA Repair Mechanisms (8 papers), PARP inhibition in cancer therapy (8 papers) and Advanced Breast Cancer Therapies (7 papers). Kelly McCann is often cited by papers focused on DNA Repair Mechanisms (8 papers), PARP inhibition in cancer therapy (8 papers) and Advanced Breast Cancer Therapies (7 papers). Kelly McCann collaborates with scholars based in United States, Australia and Japan. Kelly McCann's co-authors include Sara A. Hurvitz, Steven E. Artandi, Andrew S. Venteicher, Zhaojing Meng, Michael P. Terns, Rebecca M. Terns, Timothy D. Veenstra, Eladio Abreu, Nicholas P. McAndrew and J. Martin Brown and has published in prestigious journals such as Science, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Kelly McCann

33 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly McCann United States 12 614 277 232 90 68 36 986
Xuan Zhao China 15 598 1.0× 131 0.5× 302 1.3× 84 0.9× 123 1.8× 54 1.1k
Ryan A. Henry United States 17 927 1.5× 191 0.7× 125 0.5× 212 2.4× 71 1.0× 23 1.3k
Xiang Shen China 13 622 1.0× 175 0.6× 241 1.0× 145 1.6× 82 1.2× 33 1.0k
Nils Burger United Kingdom 15 541 0.9× 164 0.6× 86 0.4× 72 0.8× 60 0.9× 21 941
Yingying Guo China 17 389 0.6× 92 0.3× 104 0.4× 96 1.1× 42 0.6× 36 670
Jakub Karczmarski Poland 17 535 0.9× 103 0.4× 133 0.6× 155 1.7× 76 1.1× 40 856
Hui Xiao China 16 440 0.7× 112 0.4× 255 1.1× 74 0.8× 50 0.7× 54 874
Yusuke Nakamura Japan 13 414 0.7× 69 0.2× 179 0.8× 61 0.7× 62 0.9× 38 734
Diane M Spencer United States 15 712 1.2× 179 0.6× 74 0.3× 94 1.0× 36 0.5× 24 1.2k
Joyce V. Lee Singapore 13 621 1.0× 181 0.7× 128 0.6× 324 3.6× 44 0.6× 37 1.1k

Countries citing papers authored by Kelly McCann

Since Specialization
Citations

This map shows the geographic impact of Kelly McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly McCann more than expected).

Fields of papers citing papers by Kelly McCann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly McCann. The network helps show where Kelly McCann may publish in the future.

Co-authorship network of co-authors of Kelly McCann

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly McCann. A scholar is included among the top collaborators of Kelly McCann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly McCann. Kelly McCann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCann, Kelly, et al.. (2023). Updates in the treatment of HR+HER2- breast cancer. Current Opinion in Obstetrics & Gynecology. 36(1). 57–63.
2.
3.
Kirn, Dylan, Joshua D. Grill, Paul Aisen, et al.. (2023). Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment. Alzheimer s Research & Therapy. 15(1). 88–88. 2 indexed citations
4.
Wainberg, Zev A., Arun S. Singh, Gottfried E. Konecny, et al.. (2022). Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy. Clinical Cancer Research. 29(1). 40–49. 3 indexed citations
5.
6.
Llinàs‐Arias, Pere, Kelly McCann, Leonie Voorwerk, et al.. (2021). Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer. Cancers. 13(16). 4139–4139. 20 indexed citations
7.
Swinton, Marilyn, et al.. (2021). End-of-life transitions for family member on the solid tumour oncology ward: the 3 Wishes Project. BMJ Supportive & Palliative Care. 14(e1). e1472–e1477. 1 indexed citations
8.
Mahtani, Reshma, et al.. (2021). Abstract PS9-54: Healthcare costs for metastatic breast cancer patients treated with human epidermal growth factor receptor 2 targeted agents. Cancer Research. 81(4_Supplement). PS9–54. 1 indexed citations
9.
10.
McCann, Kelly & Sara A. Hurvitz. (2020). Innovations in targeted therapies for triple negative breast cancer. Current Opinion in Obstetrics & Gynecology. 33(1). 34–47. 4 indexed citations
11.
McCann, Kelly, Sara A. Hurvitz, & Nicholas P. McAndrew. (2019). Advances in Targeted Therapies for Triple-Negative Breast Cancer. Drugs. 79(11). 1217–1230. 65 indexed citations
12.
McCann, Kelly. (2019). Advances in The Use of Parp Inhibitors For Brca1/2-Associated Breast Cancer: Talazoparib. Future Oncology. 15(15). 1707–1715. 28 indexed citations
13.
McCann, Kelly & Sara A. Hurvitz. (2018). Advances in the use of PARP inhibitor therapy for breast cancer. Drugs in Context. 7. 1–30. 103 indexed citations
14.
Nakasone, Elizabeth S., Sara A. Hurvitz, & Kelly McCann. (2018). Harnessing the immune system in the battle against breast cancer. Drugs in Context. 7. 1–21. 28 indexed citations
15.
McCann, Kelly. (2018). Poly-ADP-ribosyl-polymerase inhibitor resistance mechanisms and their therapeutic implications. Current Opinion in Obstetrics & Gynecology. 31(1). 12–17. 9 indexed citations
16.
Forquer, Isaac, Ajia Town, Lillian R. Klug, et al.. (2017). Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance. Clinical Cancer Research. 23(21). 6733–6743. 11 indexed citations
17.
McCann, Kelly. (2017). Novel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer. Current Opinion in Obstetrics & Gynecology. 30(1). 7–16. 15 indexed citations
18.
McCann, Kelly, et al.. (2008). A Role for Lsm1p in Response to Ultraviolet-Radiation Damage in Saccharomyces cerevisiae. Radiation Research. 170(4). 411–421. 3 indexed citations
19.
Ross, Michael W., et al.. (2006). Outcomes of Project Wall Talk: an HIV/AIDS Peer Education Program Implemented within the Texas State Prison System. AIDS Education and Prevention. 18(6). 504–517. 43 indexed citations
20.
Gilhooly, Mary & Kelly McCann. (1985). Public knowledge of hospices: a street survey of general knowledge of hospices and specific knowledge of a local National Health Service continuing care unit.. PubMed. 43(5). 233–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuan Zhao Breakdown of academic impact, for papers by Ryan A. Henry Breakdown of academic impact, for papers by Xiang Shen Breakdown of academic impact, for papers by Nils Burger Breakdown of academic impact, for papers by Yingying Guo Breakdown of academic impact, for papers by Jakub Karczmarski Breakdown of academic impact, for papers by Hui Xiao Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Diane M Spencer Breakdown of academic impact, for papers by Joyce V. Lee
Rankless by CCL
2026